Thromboelastography in acute immunologic reactions: a prospective pilot study.
Calvin Lukas Kienbacher, Christian Schoergenhofer, Gerhard Ruzicka...
https://pubmed.ncbi.nlm.nih.gov/38974798/Actively Recruiting
Led by Mayo Clinic · Updated on 2026-10-30
250
Participants Needed
1
Research Sites
52 weeks
Total Duration
This research aims to better understand the biological mechanisms behind allergic reactions, including anaphylaxis, by studying real-time physiologic markers. The goal is to combine these markers with future molecular findings to develop better ways to classify allergic reaction types and improve risk prediction. The study is observational and focuses on acute allergic reactions. Participants will undergo blood testing using thromboelastography during their acute allergic reaction presentation to the emergency department. This test measures maximum lysis, a marker of systemic severity in allergic reactions. The study follows patients for up to four years to assess outcomes such as hospital admission and intensive care unit use. Throughout the study, participants will have thromboelastography performed during their acute episode. Researchers will collect data on the severity of allergic reactions and follow long-term outcomes. The main measurement is maximum lysis by allergic reaction severity at baseline, with secondary outcomes including hospital and intensive care utilization over four years. The study runs from October 2026 through September 2031.
CONDITIONS
Maximum Lysis on Thromboelastography as a Marker of Systemic Severity in Acute Allergic Reactions
S
Study Coordinator
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Mayo Clinic
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - During acute presentation
Participants undergo a thromboelastography blood test during their acute allergic reaction to measure maximum lysis.
1 visit (in-person)
Duration - Up to 4 years
Researchers follow participants for up to four years to track outcomes such as hospital admission and intensive care use related to allergic reactions.
Periodic follow-up assessments
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Calvin Lukas Kienbacher, Christian Schoergenhofer, Gerhard Ruzicka...
https://pubmed.ncbi.nlm.nih.gov/38974798/Mayo Clinic
Lead Sponsor